Ophthalmology News

Ophthal

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bonini-Filho M et al. - Favorable changes in BCVA and in CMT/TMV observed throughout 1 year suggest that intravitreal bevacizumab may be a viable alternative treatment for the management of patients with DME and severe capillary loss.

Related Articles

Bevacizumab Improves Macular Edema
Review of Ophthalmology, 10/02/09    Relevance Score: 69%

Phacoemulsification With Intravitreal Bevacizumab Injection in Diabetic Patients With Macular Edema and Cataract
Retina, 11/20/09    Relevance Score: 68%

Pars plana vitrectomy with ILM peeling for macular edema secondary to retinal vein occlusion
European Journal of Ophthalmology, 11/13/09    Relevance Score: 68%

Is multifocal ERG a reliable index of macular function after triamcinolone acetonide injection in diffuse diabetic macular edema
European Journal of Ophthalmology, 11/11/09    Relevance Score: 68%

Pegaptanib Sodium for Macular Edema Secondary to Branch Retinal Vein Occlusion
American Journal of Ophthalmology, 10/30/09    Relevance Score: 68%

Today in Retina...keeping you current

Pre-Treatment with Intravitreal Triamcinolone Prior to Laser for Diabetic Macular Edema: 6-Month Results of a Randomised, Placebo-Controlled Trial
Investigative Ophthalmology and Visual Science, 12/18/09

Adverse Events After Pars Plana Vitrectomy Among Medicare Beneficiaries
Archives of Ophthalmology, 12/18/09

Melanoma-Associated Retinopathy
Archives of Ophthalmology, 12/18/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address